Keywords: USA, Medical innovation, CAMI,

Council for American Medical Innovation discusses incentives to protect USA’s greatest innovators

Article | 6 October 2009

US political leaders and experts from health policy, pharmaceutical, and venture capitalist communities gathered on Capitol Hill, Washington DC, to discuss policies and incentives needed to protect and ensure continued US leadership in science and discovery. The briefing, titled Incentives for American Medical Innovation: Protecting America's Greatest Innovators, was sponsored by the Council for American Medical Innovation and was the third in a three-part series, Recovery Through Discovery, which has examined medical innovation as a driver of U.S. economic recovery and enhanced global leadership in science.

"The future of medical innovation in the USA is directly tied to our ability to encourage American businesses to invest in science and technology, and take important risks," said former Democratic Leader Richard Gephardt, chairman of the CAMI, who moderated the discussion. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in